São Paulo, November 2020 – Eurofarma, a pharmaceutical company with operations in 20 Latin American countries, strengthens its presence in Argentina by acquiring the Duloxin product from the Craveri laboratory. Duloxetine, the product’s active ingredient, is indicated for the treatment of diabetic neuropathy, major depressive disorder, and generalized anxiety disorder, which are some of the most common high prevalence disorders today.
Known for its quality and efficiency and having been available in the Argentine market for more than five years, Duloxin adds to Eurofarma’s portfolio in the country, which includes more than 60 products in different therapeutic classes and segments. The transaction reaffirms the company’s commitment to continue investing in the growth of its operations in Argentina.
Eurofarma has been in Argentina for 11 years; its recent initiatives are intended to tackle the challenge of consolidating the company’s operations in Latin America and growing inorganically in the region. The goal highlighted in Eurofarma’s Vision 2022 establishes that international operations will represent 30% of the company’s total sales on this horizon.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.
Eurofarma on social media
www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab
Youtube: @eurofarmalab